Modification of osimertinib to discover new potent EGFRC797S-TK inhibitors
Xiao-Xiao Xi, Hongyi Zhao, Yu-Ze Mao, Minhang Xin, San‐Qi Zhang
Topics & Concepts
T790MOsimertinibChemistryPharmacologyIC50Cancer researchIn vitroBiochemistryEpidermal growth factor receptorReceptorGefitinibMedicineErlotinibLung Cancer Treatments and MutationsCancer therapeutics and mechanismsColorectal Cancer Treatments and Studies